Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Is Piperacillin-Tazobactam Effective for the Treatment of Pyelonephritis Caused by ESBL-producing Organisms?

Sharara SL, Amoah J, Pana ZD, Simner PJ, Cosgrove SE, Tamma PD.

Clin Infect Dis. 2019 Dec 20. pii: ciz1205. doi: 10.1093/cid/ciz1205. [Epub ahead of print]

PMID:
31859352
2.

Evaluation of Calcium-Enhanced Media for Colistin Susceptibility Testing by Gradient Agar Diffusion and Broth Microdilution.

Green DA, Macesic N, Uhlemann AC, Lopez M, Stump S, Whittier S, Schuetz AN, Simner PJ, Humphries RM.

J Clin Microbiol. 2019 Nov 20. pii: JCM.01522-19. doi: 10.1128/JCM.01522-19. [Epub ahead of print]

PMID:
31748324
3.

Evaluation of the Direct MacConkey Method for Identification of Carbapenem-Resistant Gram-Negative Organisms from Rectal Swabs: Reevaluating Zone Diameter Cutoffs.

Workneh M, Wang R, Kazmi AQ, Chambers KK, Opene BNA, Lewis S, Goodman K, Tamma PD, Carroll KC, Milstone AM, Simner PJ.

J Clin Microbiol. 2019 Nov 22;57(12). pii: e01127-19. doi: 10.1128/JCM.01127-19. Print 2019 Dec.

PMID:
31597748
4.

Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficile.

Drewes JL, Corona A, Sanchez U, Fan Y, Hourigan SK, Weidner M, Sidhu SD, Simner PJ, Wang H, Timp W, Oliva-Hemker M, Sears CL.

JCI Insight. 2019 Oct 3;4(19). pii: 130848. doi: 10.1172/jci.insight.130848.

5.

Tailoring Antimicrobial Susceptibility Testing to Individual Species of Coagulase-Negative Staphylococci: Next Up, Staphylococcus epidermidis.

Morris CP, Simner PJ.

J Clin Microbiol. 2019 Nov 22;57(12). pii: e01391-19. doi: 10.1128/JCM.01391-19. Print 2019 Dec.

PMID:
31578262
6.

Multicenter Evaluation of Colistin Broth Disk Elution and Colistin Agar Test: a Report from the Clinical and Laboratory Standards Institute.

Humphries RM, Green DA, Schuetz AN, Bergman Y, Lewis S, Yee R, Stump S, Lopez M, Macesic N, Uhlemann AC, Kohner P, Cole N, Simner PJ.

J Clin Microbiol. 2019 Oct 23;57(11). pii: e01269-19. doi: 10.1128/JCM.01269-19. Print 2019 Nov.

PMID:
31511331
7.

Imported Cases of Extensively Drug-Resistant Salmonella.

Simner PJ, Bergman Y, Tamma PD.

Pediatr Infect Dis J. 2019 Dec;38(12):e340. doi: 10.1097/INF.0000000000002450. No abstract available.

PMID:
31469779
8.

Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States.

Tamma PD, Sharara SL, Pana ZD, Amoah J, Fisher SL, Tekle T, Doi Y, Simner PJ.

Open Forum Infect Dis. 2019 Aug 11;6(8):ofz353. doi: 10.1093/ofid/ofz353.

9.

Next-Generation Sequencing in Clinical Microbiology: Are We There Yet?

Mitchell SL, Simner PJ.

Clin Lab Med. 2019 Sep;39(3):405-418. doi: 10.1016/j.cll.2019.05.003. Review.

PMID:
31383265
10.

Multicenter Clinical Validation of the Molecular BD Max Enteric Viral Panel for Detection of Enteric Pathogens.

Stokes W, Simner PJ, Mortensen J, Oethinger M, Stellrecht K, Lockamy E, Lay T, Bouchy P, Pillai DR.

J Clin Microbiol. 2019 Aug 26;57(9). pii: e00306-19. doi: 10.1128/JCM.00306-19. Print 2019 Sep.

11.

The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during a Hospital Stay.

Tamma PD, Kazmi A, Bergman Y, Goodman KE, Ekunseitan E, Amoah J, Simner PJ.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00757-19. doi: 10.1128/AAC.00757-19. Print 2019 Aug.

PMID:
31138574
12.

Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission.

Goodman KE, Simner PJ, Klein EY, Kazmi AQ, Gadala A, Toerper MF, Levin S, Tamma PD, Rock C, Cosgrove SE, Maragakis LL, Milstone AM; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2019 May;40(5):541-550. doi: 10.1017/ice.2019.42. Epub 2019 Mar 27.

PMID:
30915928
13.

Reporting Extended-Spectrum β-Lactamase Positivity May Reduce Carbapenem Overuse.

Tamma PD, Cosgrove SE, Avdic E, Carroll KC, Simner PJ.

Open Forum Infect Dis. 2019 Feb 19;6(3):ofz064. doi: 10.1093/ofid/ofz064. eCollection 2019 Mar. No abstract available.

14.

EDTA-Modified Carbapenem Inactivation Method: a Phenotypic Method for Detecting Metallo-β-Lactamase-Producing Enterobacteriaceae.

Sfeir MM, Hayden JA, Fauntleroy KA, Mazur C, Johnson JK, Simner PJ, Das S, Satlin MJ, Jenkins SG, Westblade LF.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e01757-18. doi: 10.1128/JCM.01757-18. Print 2019 May.

15.

A Novel Phenotypic Method To Screen for Plasmid-Mediated Colistin Resistance among Enterobacteriales.

Bell DT, Bergman Y, Kazmi AQ, Lewis S, Tamma PD, Simner PJ.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e00040-19. doi: 10.1128/JCM.00040-19. Print 2019 May.

16.

A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World.

Tamma PD, Doi Y, Bonomo RA, Johnson JK, Simner PJ; Antibacterial Resistance Leadership Group .

Clin Infect Dis. 2019 Sep 27;69(8):1446-1455. doi: 10.1093/cid/ciz173.

PMID:
30838380
17.

Applying Rapid Whole-Genome Sequencing To Predict Phenotypic Antimicrobial Susceptibility Testing Results among Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates.

Tamma PD, Fan Y, Bergman Y, Pertea G, Kazmi AQ, Lewis S, Carroll KC, Schatz MC, Timp W, Simner PJ.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01923-18. doi: 10.1128/AAC.01923-18. Print 2019 Jan.

18.

Two-Site Evaluation of the Colistin Broth Disk Elution Test To Determine Colistin In Vitro Activity against Gram-Negative Bacilli.

Simner PJ, Bergman Y, Trejo M, Roberts AA, Marayan R, Tekle T, Campeau S, Kazmi AQ, Bell DT, Lewis S, Tamma PD, Humphries R, Hindler JA.

J Clin Microbiol. 2019 Jan 30;57(2). pii: e01163-18. doi: 10.1128/JCM.01163-18. Print 2019 Feb.

19.

How frequently are hospitalized patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) already on contact precautions for other indications?

Goodman KE, Simner PJ, Klein EY, Kazmi AQ, Gadala A, Rock C, Tamma PD, Cosgrove SE, Maragakis LL, Milstone AM; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2018 Dec;39(12):1491-1493. doi: 10.1017/ice.2018.236. Epub 2018 Oct 1.

20.

Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates.

Tamma PD, Simner PJ.

J Clin Microbiol. 2018 Oct 25;56(11). pii: e01140-18. doi: 10.1128/JCM.01140-18. Print 2018 Nov. Review.

21.

Identification of infectious organisms in cytopathology: A review of ancillary diagnostic techniques.

Allison DB, Simner PJ, Ali SZ.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:643-653. doi: 10.1002/cncy.22023. Review.

22.

Comparison of nylon-flocked swab and cellulose sponge methods for carbapenem-resistant Enterobacteriaceae and gram-negative organism recovery from high-touch surfaces in patient rooms.

Rock C, Anderson M, Lewis S, Scheeler V, Nowakowski E, Hsu YJ, Milstone AM, Carroll KC, Maragakis LL, Simner PJ; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2018 Oct;39(10):1257-1261. doi: 10.1017/ice.2018.182. Epub 2018 Aug 28.

23.

Development and Optimization of Metagenomic Next-Generation Sequencing Methods for Cerebrospinal Fluid Diagnostics.

Simner PJ, Miller HB, Breitwieser FP, Pinilla Monsalve G, Pardo CA, Salzberg SL, Sears CL, Thomas DL, Eberhart CG, Carroll KC.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00472-18. doi: 10.1128/JCM.00472-18. Print 2018 Sep.

24.

Using Patient Risk Factors to Identify Whether Carbapenem-Resistant Enterobacteriaceae Infections Are Caused by Carbapenemase-Producing Organisms.

Simner PJ, Goodman KE, Carroll KC, Harris AD, Han JH, Tamma PD.

Open Forum Infect Dis. 2018 May 17;5(5):ofy094. doi: 10.1093/ofid/ofy094. eCollection 2018 May.

25.

Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniae.

Simner PJ, Antar AAR, Hao S, Gurtowski J, Tamma PD, Rock C, Opene BNA, Tekle T, Carroll KC, Schatz MC, Timp W.

J Antimicrob Chemother. 2018 Jul 1;73(7):1796-1803. doi: 10.1093/jac/dky121.

26.

Successful Treatment of Persistent Burkholderia cepacia Complex Bacteremia with Ceftazidime-Avibactam.

Tamma PD, Fan Y, Bergman Y, Sick-Samuels AC, Hsu AJ, Timp W, Simner PJ, Prokesch BC, Greenberg DE.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02213-17. doi: 10.1128/AAC.02213-17. Print 2018 Apr.

27.

Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis.

Pancholi P, Carroll KC, Buchan BW, Chan RC, Dhiman N, Ford B, Granato PA, Harrington AT, Hernandez DR, Humphries RM, Jindra MR, Ledeboer NA, Miller SA, Mochon AB, Morgan MA, Patel R, Schreckenberger PC, Stamper PD, Simner PJ, Tucci NE, Zimmerman C, Wolk DM.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01329-17. doi: 10.1128/JCM.01329-17. Print 2018 Apr.

28.

Risk Factors for Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Carriage Upon Pediatric Intensive Care Unit Admission.

Li DX, Sick-Samuels AC, Suwantarat N, Same RG, Simner PJ, Tamma PD.

Infect Control Hosp Epidemiol. 2018 Jan;39(1):116-118. doi: 10.1017/ice.2017.246. Epub 2017 Dec 5. No abstract available.

29.

Multicenter Evaluation of the Modified Carbapenem Inactivation Method and the Carba NP for Detection of Carbapenemase-Producing Pseudomonas aeruginosa and Acinetobacter baumannii.

Simner PJ, Johnson JK, Brasso WB, Anderson K, Lonsway DR, Pierce VM, Bobenchik AM, Lockett ZC, Charnot-Katsikas A, Westblade LF, Yoo BB, Jenkins SG, Limbago BM, Das S, Roe-Carpenter DE.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01369-17. doi: 10.1128/JCM.01369-17. Print 2018 Jan.

30.

Understanding the Promises and Hurdles of Metagenomic Next-Generation Sequencing as a Diagnostic Tool for Infectious Diseases.

Simner PJ, Miller S, Carroll KC.

Clin Infect Dis. 2018 Feb 10;66(5):778-788. doi: 10.1093/cid/cix881. Review.

PMID:
29040428
31.

Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?

Tamma PD, Wang R, Lewis S, Opene BNA, Simner PJ.

Infect Control Hosp Epidemiol. 2017 Nov;38(11):1378-1379. doi: 10.1017/ice.2017.210. Epub 2017 Oct 2. No abstract available.

32.

Multisite Evaluation of the BD Max Extended Enteric Bacterial Panel for Detection of Yersinia enterocolitica, Enterotoxigenic Escherichia coli, Vibrio, and Plesiomonas shigelloides from Stool Specimens.

Simner PJ, Oethinger M, Stellrecht KA, Pillai DR, Yogev R, Leblond H, Mortensen J.

J Clin Microbiol. 2017 Nov;55(11):3258-3266. doi: 10.1128/JCM.00911-17. Epub 2017 Sep 6.

33.

Carbapenemase Detection among Carbapenem-Resistant Glucose-Nonfermenting Gram-Negative Bacilli.

Simner PJ, Opene BNA, Chambers KK, Naumann ME, Carroll KC, Tamma PD.

J Clin Microbiol. 2017 Sep;55(9):2858-2864. doi: 10.1128/JCM.00775-17. Epub 2017 Jul 12.

34.

Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae.

Pierce VM, Simner PJ, Lonsway DR, Roe-Carpenter DE, Johnson JK, Brasso WB, Bobenchik AM, Lockett ZC, Charnot-Katsikas A, Ferraro MJ, Thomson RB Jr, Jenkins SG, Limbago BM, Das S.

J Clin Microbiol. 2017 Aug;55(8):2321-2333. doi: 10.1128/JCM.00193-17. Epub 2017 Apr 5.

35.

Comparison of 11 Phenotypic Assays for Accurate Detection of Carbapenemase-Producing Enterobacteriaceae.

Tamma PD, Opene BN, Gluck A, Chambers KK, Carroll KC, Simner PJ.

J Clin Microbiol. 2017 Apr;55(4):1046-1055. doi: 10.1128/JCM.02338-16. Epub 2017 Jan 11.

36.

Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.

Tamma PD, Goodman KE, Harris AD, Tekle T, Roberts A, Taiwo A, Simner PJ.

Clin Infect Dis. 2017 Feb 1;64(3):257-264. doi: 10.1093/cid/ciw741. Epub 2016 Nov 9.

37.

Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories?

Mizusawa M, Miller H, Green R, Lee R, Durante M, Perkins R, Hewitt C, Simner PJ, Carroll KC, Hayden RT, Zhang SX.

J Clin Microbiol. 2017 Feb;55(2):638-640. doi: 10.1128/JCM.02202-16. Epub 2016 Nov 23. No abstract available.

38.

Bypass graft infection and bacteremia caused by Anaerostipes caccae: First report of human infection caused by a recently described gut anaerobe.

Workneh M, Wang F, Romagnoli M, Simner PJ, Carroll K.

Anaerobe. 2016 Dec;42:98-100. doi: 10.1016/j.anaerobe.2016.09.005. Epub 2016 Sep 28.

PMID:
27693544
39.

Mycobacteria.

Simner PJ, Woods GL, Wengenack NL.

Microbiol Spectr. 2016 Aug;4(4). doi: 10.1128/microbiolspec.DMIH2-0016-2015.

PMID:
27726808
40.

Determining the Optimal Carbapenem MIC That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae.

Tamma PD, Huang Y, Opene BN, Simner PJ.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6425-9. doi: 10.1128/AAC.00838-16. Print 2016 Oct.

41.

Medical Parasitology Taxonomy Update: January 2012 to December 2015.

Simner PJ.

J Clin Microbiol. 2016 Dec 28;55(1):43-47. doi: 10.1128/JCM.01020-16. Print 2017 Jan. Review.

42.

First Report of a Verona Integron-Encoded Metallo-β-Lactamase-Producing Klebsiella pneumoniae Infection in a Child in the United States.

Tamma PD, Suwantarat N, Rudin SD, Logan LK, Simner PJ, Rojas LJ, Mojica MF, Carroll KC, Bonomo RA.

J Pediatric Infect Dis Soc. 2016 Sep;5(3):e24-7. doi: 10.1093/jpids/piw025. Epub 2016 May 4.

43.

Evaluation of Multiple Methods for Detection of Gastrointestinal Colonization of Carbapenem-Resistant Organisms from Rectal Swabs.

Simner PJ, Martin I, Opene B, Tamma PD, Carroll KC, Milstone AM.

J Clin Microbiol. 2016 Jun;54(6):1664-1667. doi: 10.1128/JCM.00548-16. Epub 2016 Apr 6.

44.

Carbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the Puzzle.

Gniadek TJ, Carroll KC, Simner PJ.

J Clin Microbiol. 2016 Jul;54(7):1700-1710. doi: 10.1128/JCM.03264-15. Epub 2016 Feb 24. Review.

45.

Mycobacterium and Aerobic Actinomycete Culture: Are Two Medium Types and Extended Incubation Times Necessary?

Simner PJ, Doerr KA, Steinmetz LK, Wengenack NL.

J Clin Microbiol. 2016 Apr;54(4):1089-93. doi: 10.1128/JCM.02838-15. Epub 2016 Feb 10.

46.

The Prevalence and Molecular Epidemiology of Multidrug-Resistant Enterobacteriaceae Colonization in a Pediatric Intensive Care Unit.

Suwantarat N, Logan LK, Carroll KC, Bonomo RA, Simner PJ, Rudin SD, Milstone AM, Tekle T, Ross T, Tamma PD.

Infect Control Hosp Epidemiol. 2016 May;37(5):535-43. doi: 10.1017/ice.2016.16. Epub 2016 Feb 9.

47.

Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).

Goodman KE, Simner PJ, Tamma PD, Milstone AM.

Expert Rev Anti Infect Ther. 2016;14(1):95-108. doi: 10.1586/14787210.2016.1106940. Epub 2015 Nov 4. Review.

PMID:
26535959
48.

Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013).

Simner PJ, Adam H, Baxter M, McCracken M, Golding G, Karlowsky JA, Nichol K, Lagacé-Wiens P, Gilmour MW; Canadian Antimicrobial Resistance Alliance (CARA), Hoban DJ, Zhanel GG.

Antimicrob Agents Chemother. 2015 Jul;59(7):4315-7. doi: 10.1128/AAC.00384-15. Epub 2015 Apr 20.

49.

Evaluation of five chromogenic agar media and the Rosco Rapid Carb screen kit for detection and confirmation of carbapenemase production in Gram-negative bacilli.

Simner PJ, Gilmour MW, DeGagne P, Nichol K, Karlowsky JA.

J Clin Microbiol. 2015 Jan;53(1):105-12. doi: 10.1128/JCM.02068-14. Epub 2014 Oct 29.

50.

Tenosynovitis caused by a novel nontuberculous Mycobacterium species initially misidentified as a member of the Mycobacterium tuberculosis complex.

Simner PJ, Hyle EP, Buckwalter SP, Branda JA, Brown-Elliott BA, Franklin J, Toney NC, de Man TJ, Wallace RJ Jr, Vasireddy R, Gandhi RT, Wengenack NL.

J Clin Microbiol. 2014 Dec;52(12):4414-8. doi: 10.1128/JCM.00967-14. Epub 2014 Sep 24.

Supplemental Content

Loading ...
Support Center